The Global Hepatitis Association was established as a non-profit corporation by the Government of Canada in September 2016.

The mission of The Global Hepatitis Association (GHA) is to lead and accelerate the global effort to eliminate hepatitis B as a public health threat by fostering scientific innovation, promoting equitable access to prevention and treatment, and facilitating collaboration between academia, industry, and public health stakeholders. Through the annual International HBV Cure Workshop and strategic partnerships, we aim to advance curative therapies, support evidence-based policy, and empower communities worldwide to overcome the burden of hepatitis B.

Directors:

• Dr. Adam Gehring – Toronto Centre for Liver Disease (Toronto, Canada)
• Dr. Harry Janssen – Erasmus MC, University Hospital (Rotterdam, the Netherlands) and Toronto Centre for Liver Disease (Toronto, Canada)
• Dr. Jordan Feld – University Health Network Francis Family Liver Clinic (Toronto, Canada)

Contact:

• Dr. Adam Gehring: adam.gehring@uhn.ca